Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
211M
-
Number of holders
-
411
-
Total 13F shares, excl. options
-
188M
-
Shares change
-
+12M
-
Total reported value, excl. options
-
$13.7B
-
Value change
-
+$901M
-
Put/Call ratio
-
1.43
-
Number of buys
-
254
-
Number of sells
-
-147
-
Price
-
$73.00
Significant Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) as of Q3 2024
514 filings reported holding INSM - INSMED Inc - Common Stock, par value $0.01 per share as of Q3 2024.
INSMED Inc - Common Stock, par value $0.01 per share (INSM) has 411 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 188M shares
of 211M outstanding shares and own 89.17% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (17.1M shares), BlackRock, Inc. (15M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.6M shares), Darwin Global Management, Ltd. (10.5M shares), FMR LLC (7.19M shares), Capital International Investors (6.52M shares), STATE STREET CORP (6.18M shares), BAKER BROS. ADVISORS LP (4.42M shares), GEODE CAPITAL MANAGEMENT, LLC (3.81M shares), and JPMORGAN CHASE & CO (3.31M shares).
This table shows the top 411 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.